Skip to content

HOPE-HFrEF: Prospective cohort study on perioperative and long-term outcomes in patients with heart failure with reduced ejection fraction undergoing isolated off-pump coronary artery bypass grafting

HOPE-HFrEF: Prospective cohort study on perioperative and long-term outcomes in patients with heart failure with reduced ejection fraction undergoing isolated off-pump coronary artery bypass grafting - HOPE-HFrEF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040171
Enrollment
200
Registered
2026-06-15
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50.1

Interventions

Group 1: Prospective observational cohort of adult patients with heart failure with reduced left ventricular ejection fraction scheduled for isolated off-pump coronary artery bypass grafting at the Un

Sponsors

Universitätsklinikum der Eberhard-Karls-Universität Tübingen, Klinik für Thorax-, Herz- und Gefäßchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients aged 18 years or older with heart failure with reduced left ventricular ejection fraction, defined as a preoperative left ventricular ejection fraction =40%, scheduled for isolated coronary artery bypass grafting without primary use of cardiopulmonary bypass at the University Hospital Tübingen are eligible for inclusion. Additional inclusion criteria are: - planned isolated coronary artery bypass grafting on the beating heart, - ability to participate in the study and follow-up assessments, - written informed consent provided by the patient after study information.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: - age below 18 years, - absence or withdrawal of written informed consent, - primarily planned coronary artery bypass grafting with cardiopulmonary bypass, - combined cardiac surgical procedures in addition to coronary artery bypass grafting, for example valve surgery or aortic surgery, - absence of heart failure with reduced left ventricular ejection fraction according to the study protocol, - inability to collect the baseline and follow-up data required for the study. Intraoperative conversion from an initially planned off-pump procedure to a procedure with cardiopulmonary bypass is documented as a perioperative event and does not automatically lead to exclusion from the study.

Design outcomes

Primary

MeasureTime frame
As this is a prospective, non-interventional cohort study with several predefined perioperative and long-term outcome domains, no single primary endpoint in the sense of an interventional efficacy trial is defined. The primary aim of the study is the prospective and standardized characterization of the perioperative and postoperative clinical course of adult patients with heart failure with reduced left ventricular ejection fraction undergoing isolated off-pump coronary artery bypass grafting. For this purpose, preoperative risk factors, intraoperative treatment data, postoperative intensive care and ward trajectories, and clinical outcomes are assessed during the index hospital stay, at 30 days, and at 6, 12, and 24 months. Data are collected from routine clinical documentation, including operative reports, intensive care and ward records, laboratory and imaging findings, discharge summaries and follow-up contacts, and are documented in a standardized electronic case report form (REDCap eCRF).

Secondary

MeasureTime frame
Secondary outcomes include in-hospital mortality, 30-day mortality, and mortality at 6, 12, and 24 months, major adverse cardiac and cerebrovascular events (MACCE), myocardial infarction, stroke, repeat revascularization, postoperative low cardiac output syndrome, intraoperative conversion to on-pump CABG, need for catecholamines or mechanical circulatory support, acute kidney injury according to KDIGO criteria, need for renal replacement therapy, blood loss, transfusion requirements, surgical revision for bleeding, duration of mechanical ventilation, prolonged ventilation, reintubation, tracheostomy, intensive care unit and hospital length of stay, delirium, neurological complications, infections, sepsis, wound complications, readmission, quality of life, and functional status during follow-up. Secondary outcomes are assessed perioperatively, during the index hospital stay, at the 30-day follow-up, and at 6, 12, and 24 months. Data are collected from routine clinical documentation, laboratory and imaging findings, intensive care and ward records, validated or standardized clinical scores, discharge summaries, and follow-up contacts, and are documented in the REDCap eCRF.

Countries

Germany

Contacts

Public ContactChristian Rustenbach

Universtitätsklinikum der Eberhard-Karls-Universität Tübingen, Klinik für Thorax-, Herz- und Gefäßchirurgie

christian.rustenbach@med.uni-tuebingen.de070712986638

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026